Rasmussen LB, Andersen NL, Andersson G, Lange AP, Rasmussen K, et al. Folate and neural tube defects Recommendations from a Danish working group. Dan Med Bull. 1998;45(2):213–7.
Green NS. Folic acid supplementation and prevention of birth defects. J Nutr. 2002;132(Suppl 8):2356S-2360S.
Czeizel AE. Primary prevention of neural-tube defects and some other major congenital abnormalities: recommendations for the appropriate use of folic acid during pregnancy. Paediatr Drugs. 2000;2(6):437–49.
Nguyen MT, Hendrickx IM. Model studies on the stability of folic acid and 5-methyltetrahydrofolic acid degradation during thermal treatment in combination with high hydrostatic pressure. J Agric Food Chem. 2003;51(11):3352–7.
Ohrvik VE, Witthoft CM. Human folate bioavailability. Nutrients. 2011;3(4):475–90.
Liu Y, Chen S, Zühlke L, Black GC, Choy MK, Li N, et al. Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol. 2019;48(2):455–63.
van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58(21):2241–7.
Berry RJ, Li Z, Erickson JD, Li S, Moore CA, et al. Prevention of neural-tube defects with folic acid in China. China-U.S. collaborative project for neural tube defect prevention. N Engl J Med. 1999;341(20):1485–90.
National Health Commission of the People's Republic of China. China Maternal and Child Health Development Report (2019) (I). Chinese Journal of Women and Children Health. 2019;10(5):1–8.
Ministry of Health of the People's Republic of China. China Birth Defect Prevention Report. 2012. http://www.gov.cn/gzdt/att/att/site1/20120912/1c6f6506c7f811bacf9301.pdf. accessed 13 August 2021.
Xu WL, Deng CF, Li WY, Wang K, Tao J, Gao YY, et al. National perinatal prevalence of selected major birth defects — China, 2010–2018. China CDC Wkly. 2020;2(37):711–7.
Zhao L, Chen L, Yang T, Wang T, Zhang S, et al. Birth prevalence of congenital heart disease in China, 1980–2019: a systematic review and meta-analysis of 617 studies. Eur J Epidemiol. 2020;35(7):631–42.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.
Wells GA, Shea B, O'Connell D, Peterson J, Welch V, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses comparison. http://www.ohri.ca/programs/clinical_epidemiology /oxford.asp. accessed 13 August 2021.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101.
Correa A, Gilboa SM, Botto LD, Moore CA, Hobbs CA, et al. Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects. Am J Obstet Gynecol. 2012;206(3):218.e1-13.
Scanlon KS, Ferencz C, Loffredo CA, Wilson PD, Correa-Villaseñor A, et al. Preconceptional folate intake and malformations of the cardiac outflow tract. Baltim-Wash Infant Study Group Epidemiol. 1998;9(1):95–8.
Werler MM, Hayes C, Louik C, Shapiro S, Mitchell AA. Multivitamin supplementation and risk of birth defects. Am J Epidemiol. 1999;150(7):675–82.
Shaw GM, Carmichael SL, Yang W, Lammer EJ. Periconceptional nutrient intakes and risks of conotruncal heart defects. Birth Defects Res A Clin Mol Teratol. 2010;88(3):144–51.
Shaw GM, O’Malley CD, Wasserman CR, Tolarova MM, Lammer EJ. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet. 1995;59(4):536–45.
Øyen N, Olsen SF, Basit S, Leirgul E, Strøm M, et al. Association between maternal folic acid supplementation and congenital heart defects in offspring in birth cohorts from Denmark and Norway. J Am Heart Assoc. 2019;8(6):e011615.
Csáky-Szunyogh M, Vereczkey A, Kósa Z, Urbán R, Czeizel AE. Association of maternal diseases during pregnancy with the risk of single ventricular septal defects in the offspring–a population-based case-control study. J Matern Fetal Neonatal Med. 2013;26(8):738–47.
Czeizel AE, Vereczkey A, Szabó I. Folic acid in pregnant women associated with reduced prevalence of severe congenital heart defects in their children: a national population-based case-control study. Eur J Obstet Gynecol Reprod Biol. 2015;193:34–9.
Leirgul E, Gildestad T, Nilsen RM, Fomina T, Brodwall K, et al. Periconceptional folic acid supplementation and infant risk of congenital heart defects in Norway 1999–2009. Paediatr Perinat Epidemiol. 2015;29(5):391–400.
Csáky-Szunyogh M, Vereczkey A, Urbán R, Czeizel AE. Risk and protective factors in the origin of atrial septal defect secundum–national population-based case-control study. Cent Eur J Public Health. 2014;22(1):42–7.
Csáky-Szunyogh M, Vereczkey A, Kósa Z, Gerencsér B, Czeizel AE. Risk and protective factors in the origin of conotruncal defects of heart–a population-based case-control study. Am J Med Genet A. 2013;161A(10):2444–52.
van Beynum IM, Kapusta L, Bakker MK, den Heijer M, Blom HJ, de Walle HE. Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands. Eur Heart J. 2010;31(4):464–71.
Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ. 1993;306(6893):1645–8.
Czeizel AE, Dobó M, Vargha P. Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Res A Clin Mol Teratol. 2004;70(11):853–61.
Li X, Li S, Mu D, Liu Z, Li Y, Lin Y, et al. The association between periconceptional folic acid supplementation and congenital heart defects: a case-control study in China. Prev Med. 2013;56(6):385–9.
Qu Y, Lin S, Zhuang J, Bloom MS, Smith M, et al. First-trimester maternal folic acid supplementation reduced risks of severe and most congenital heart diseases in offspring: a large case-control study. J Am Heart Assoc. 2020;9(13):e015652.
Feng Y, Cai J, Tong X, Chen R, Zhu Y, Xu B, Mo X. Non-inheritable risk factors during pregnancy for congenital heart defects in offspring: A matched case-control study. Int J Cardiol. 2018;264:45–52.
Mao B, Qiu J, Zhao N, Shao Y, Dai W, et al. Maternal folic acid supplementation and dietary folate intake and congenital heart defects. PLoS One. 2017;12(11):e0187996.
Liu S, Joseph KS, Luo W, León JA, Lisonkova S, et al. Effect of folic acid food fortification in Canada on congenital heart disease subtypes. Circulation. 2016;134(9):647–55.
Bedard T, Lowry RB, Sibbald B, Harder JR, Trevenen C, et al. Folic acid fortification and the birth prevalence of congenital heart defect cases in Alberta, Canada. Birth Defects Res A Clin Mol Teratol. 2013;97(8):564–70.
Bower C, Miller M, Payne J, Serna P. Folate intake and the primary prevention of non-neural birth defects. Aust N Z J Public Health. 2006;30(3):258–61.
Song JW, Chung KC. Observational studies: cohort and case-control studies. Plast Reconstr Surg. 2010;126(6):2234–42.
Bradley EA, Zaidi AN. Atrial septal defect. Cardiol Clin. 2020;38(3):317–24.
Han X, Wang B, Jin D, et al. Precise dose of folic acid supplementation is essential for embryonic heart development in Zebrafish. Biology (Basel). 2021;11(1):28.
Li Q, Zhang Y, Huang L, Zhong C, Chen R, et al. High-dose folic acid supplement use from prepregnancy through midpregnancy is associated with increased risk of gestational diabetes mellitus: a prospective cohort study. Diabetes Care. 2019;42(7):e113–5.
Li Q, Xu S, Chen X, Zhang X, Li X, et al. Folic acid supplement use and increased risk of gestational hypertension. Hypertension. 2020;76(1):150–6.
Sinclair KD, Allegrucci C, Singh R, Gardner DS, Sebastian S, et al. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc Natl Acad Sci U S A. 2007;104(49):19351–6.
Czeizel AE, Bánhidy F. Vitamin supply in pregnancy for prevention of congenital birth defects. Curr Opin Clin Nutr Metab Care. 2011;14(3):291–6.
Elizabeth KE, Praveen SL, Preethi NR, Jissa VT, Pillai MR. Folate, vitamin B12, homocysteine and polymorphisms in folate metabolizing genes in children with congenital heart disease and their mothers. Eur J Clin Nutr. 2017;71(12):1437–41.
Tang LS, Wlodarczyk BJ, Santillano DR, Miranda RC, Finnell RH. Developmental consequences of abnormal folate transport during murine heart morphogenesis. Birth Defects Res A Clin Mol Teratol. 2004;70(7):449–58.
Zhang X, Liu J, Jin Y, et al. Folate of pregnant women after a nationwide folic acid supplementation in China. Matern Child Nutr. 2019;15(4):e12828.
Wang S, Ge X, Zhu B, Xuan Y, Huang K, et al. Maternal continuing folic acid supplementation after the first trimester of pregnancy increased the risk of large-for-gestational-age birth: a population-based birth cohort study. Nutrients. 2016;8(8):493.
Brown SB, Reeves KW, Bertone-Johnson ER. Maternal folate exposure in pregnancy and childhood asthma and allergy: a systematic review. Nutr Rev. 2014;72(1):55–64.
Chen Z, Xing Y, Yu X, Dou Y, Ma D. Effect of folic acid intake on infant and child allergic diseases: systematic review and meta-analysis. Front Pediatr. 2021;8:615406.
DeSoto MC, Hitlan RT. Synthetic folic acid supplementation during pregnancy may increase the risk of developing autism. J Pediatr Biochem. 2012;2:251–61.
Raghavan R, Riley AW, Volk H, Caruso D, Hironaka L, et al. Maternal multivitamin intake, plasma folate and vitamin B12 levels and autism spectrum disorder risk in offspring. Paediatr Perinat Epidemiol. 2018;32(1):100–11.